Literature DB >> 24040485

Impact of brand-name drug worship and expectation psychology on antidepressant efficacy.

Jian Cai1, Meirong Ye, Chunhua Fei, Feng Xu.   

Abstract

The choice of the generic drug is reasonable if there is evidence for its therapeutic equivalence with the brand-name drug. However, the reduced effectiveness of switching from brand-name drug to generic drug is not rare. The impact of brand-name worship and expectation psychology on drug efficacy is noteworthy to report. A 45-year-old woman suffered from depression mood disorder. She experienced profound improvement in her depressive symptoms after a switch from domestic generic venlafaxine to imported brand-name counterpart. The interview showed that the woman has a strong brand-name drug worship and expectation psychology, which is representative, typical and popular in China especially in vast rural areas. Medication education does not work too much. The brand-name drug worship and expectation psychology might improve drug efficacy when patient is switched from generic drug to branded medication.

Entities:  

Keywords:  Antidepressant; brand-name; difference; generic; psychology

Year:  2013        PMID: 24040485      PMCID: PMC3762632     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  12 in total

1.  Case reports of the reemergence of psychotic symptoms after conversion from brand-name clozapine to a generic formulation.

Authors:  R Mofsen; J Balter
Journal:  Clin Ther       Date:  2001-10       Impact factor: 3.393

Review 2.  Switching from brand-name to generic psychotropic medications: a literature review.

Authors:  Julie Eve Desmarais; Linda Beauclair; Howard C Margolese
Journal:  CNS Neurosci Ther       Date:  2010-11-30       Impact factor: 5.243

3.  Commercial features of placebo and therapeutic efficacy.

Authors:  Rebecca L Waber; Baba Shiv; Ziv Carmon; Dan Ariely
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

4.  Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe.

Authors:  Atholl Johnston; Roland Asmar; Björn Dahlöf; Kate Hill; David Albert Jones; Jens Jordan; Michael Livingston; Graham Macgregor; Michael Sobanja; Panagiotis Stafylas; Enrico Agabiti Rosei; José Zamorano
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

5.  The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.

Authors:  Aaron S Kesselheim
Journal:  CMAJ       Date:  2011-07-11       Impact factor: 8.262

6.  [Domestic imipenem cilastatin sodium for the treatment of severe aspiration pneumonia, a curative effect observation].

Authors:  Hai-yan Yin; Xiao-ling Ye; Rui Zhang; You-feng Zhu
Journal:  Zhongguo Wei Zhong Bing Ji Jiu Yi Xue       Date:  2012-10

7.  Beliefs about generic drugs among elderly adults in hospital-based primary care practices.

Authors:  Alice Iosifescu; Ethan A Halm; Thomas McGinn; Albert L Siu; Alex D Federman
Journal:  Patient Educ Couns       Date:  2008-11

8.  [The long-term efficacy of lamivudine in chronic hepatitis B: interim analysis of 3-year's clinical course].

Authors:  Guang-bi Yao; Bao-en Wang; Zhen-yu Cui; Ji-lu Yao; Min-de Zeng
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2003-06

9.  [A comparison of the efficacy and safety of domestic orlistat and imported orlistat in Chinese overweight and obese patients].

Authors:  Hui-juan Zhu; Hui Pan; Feng-ying Gong; Xiao-feng Lü; Yong-de Peng; Zhi-min Liu; Cheng-jiang Li; Ye-rong Yu; Qiu-he Ji; Xiao-ping Xing
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2009-10

10.  What's in a name? Use of brand versus generic drug names in United States outpatient practice.

Authors:  Michael A Steinman; Mary-Margaret Chren; C Seth Landefeld
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

View more
  1 in total

1.  Drug Brand Response and Its Impact on Compliance and Efficacy in Depression Patients.

Authors:  Mingming Li; Jian Cai; Ping Zhang; Chunhua Fei; Feng Xu
Journal:  Front Pharmacol       Date:  2017-01-10       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.